TG THERAPEUTICS, INC. Proceeds from (Repayments of) Secured Debt
TG THERAPEUTICS, INC. (TGTX) reported Proceeds from (Repayments of) Secured Debt of -$255.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfSecuredDebt · last filed 2026-08-05
- TG THERAPEUTICS, INC. proceeds from (repayments of) secured debt for the quarter ending 2026-06-30 was $0.00.
- TG THERAPEUTICS, INC. proceeds from (repayments of) secured debt for the quarter ending 2026-03-31 was -$255.00M.
- TG THERAPEUTICS, INC. proceeds from (repayments of) secured debt for the quarter ending 2025-12-31 was $0.00.
- TG THERAPEUTICS, INC. proceeds from (repayments of) secured debt for the quarter ending 2025-09-30 was $0.00.
- TG THERAPEUTICS, INC. proceeds from (repayments of) secured debt for fiscal 2025 was $0.00.
- TG THERAPEUTICS, INC. proceeds from (repayments of) secured debt for fiscal 2024 was -$107.55M.
- TG THERAPEUTICS, INC. proceeds from (repayments of) secured debt for fiscal 2023 was $0.00.
- TG THERAPEUTICS, INC. proceeds from (repayments of) secured debt for fiscal 2022 was -$975.00K.
| Period end | Proceeds from (Repayments of) Secured Debt 3 month | Proceeds from (Repayments of) Secured Debt 6 month | Proceeds from (Repayments of) Secured Debt 9 month | Proceeds from (Repayments of) Secured Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$255.00M 10-Q · filed 2026-08-05 | -$255.00M derived: sum of 3 quarters · filed 2026-08-05 | -$255.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$255.00M 10-Q · filed 2026-05-06 | -$255.00M derived: sum of 2 quarters · filed 2026-05-06 | -$255.00M derived: sum of 3 quarters · filed 2026-05-06 | -$255.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $0.00 derived: sum of 3 quarters · filed 2026-08-05 | $0.00 10-K · filed 2026-02-27 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2026-08-05 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | $0.00 derived: sum of 3 quarters · filed 2026-08-05 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-05-06 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$107.55M 10-K · filed 2026-02-27 | ||
| 2024-09-30 | -$107.55M 10-Q · filed 2025-11-05 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 10-K · filed 2026-02-27 | ||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $0.00 derived: sum of 2 quarters · filed 2025-03-03 | $0.00 derived: sum of 3 quarters · filed 2025-03-03 | -$975.00K 10-K · filed 2025-03-03 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $0.00 derived: sum of 2 quarters · filed 2023-11-06 | -$975.00K 10-Q · filed 2023-11-06 | -$16.39M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$975.00K 10-Q · filed 2023-08-04 | -$16.39M derived: sum of 3 quarters · filed 2024-02-29 | -$23.77M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$975.00K 10-Q · filed 2023-05-08 | -$16.39M derived: sum of 2 quarters · filed 2024-02-29 | -$23.77M derived: sum of 3 quarters · filed 2024-02-29 | |
| 2021-12-31 | -$15.41M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$22.80M derived: sum of 2 quarters · filed 2024-02-29 | -$30.00M 10-K · filed 2024-02-29 | |
| 2021-09-30 | -$7.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$14.59M 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | -$7.20M 10-Q · filed 2022-08-09 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-01 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |